Yoon Jin Roh, Kui Young Park, Na Yeon Koo, Yong Hee Choi, Hye Won Song, Sin Woo Sung, Ka Ram Kim, Seong Jun Seo, Joon Seok, Mi-Kyung Lee
{"title":"颗粒物质通过HDACs和聚丝蛋白改变对特应性皮炎的影响。","authors":"Yoon Jin Roh, Kui Young Park, Na Yeon Koo, Yong Hee Choi, Hye Won Song, Sin Woo Sung, Ka Ram Kim, Seong Jun Seo, Joon Seok, Mi-Kyung Lee","doi":"10.4014/jmb.2502.02047","DOIUrl":null,"url":null,"abstract":"<p><p>Atopic dermatitis (AD) is a skin condition that can be exacerbated by particulate matter (PM). The primary causes of AD are believed to be impairments in the skin barrier, such as filaggrin (FLG) abnormalities. Although there is substantial evidence for genetic factors contributing to AD, it is challenging to attribute the disease's predisposition solely to genetics. We hypothesize that PM may induce epigenetic modifications in AD, impacting FLG expression. Here, we assessed histone deacetylases (HDACs) and FLG levels under AD conditions with or without exposure to PM using qRT-PCR, western blotting, and immunofluorescence. Additionally, we observed changes in these molecules when co-treated with the HDAC inhibitor, trichostatin A (TSA). FLG levels tended to decrease when PM or IL-4/13 were given individually, and a further decrease upon IL-4/13 and PM cotreatment. Interestingly, HDAC3 and HDAC6 are increased when they were both given PM10 and IL-4/13 co-treatment compared to IL-4/13 treatment alone. FLG levels exhibited a significant restoration and the levels of HDACs were changed when treated with TSA than with IL-4/13 or IL-4/13+PM co-treatment. We found changes in FLG and HDACs in the AD-like in vivo model and in this model with PM. Our findings suggest that PM can induce epigenetic alterations in AD. Treatment with TSA ameliorates these effects on FLG expression, indicating its potential as a novel therapeutic approach for AD.</p>","PeriodicalId":16481,"journal":{"name":"Journal of microbiology and biotechnology","volume":"35 ","pages":"e2502047"},"PeriodicalIF":3.1000,"publicationDate":"2025-07-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12324990/pdf/","citationCount":"0","resultStr":"{\"title\":\"Effect of Particulate Matter in Atopic Dermatitis through HDACs and Filaggrin Alteration.\",\"authors\":\"Yoon Jin Roh, Kui Young Park, Na Yeon Koo, Yong Hee Choi, Hye Won Song, Sin Woo Sung, Ka Ram Kim, Seong Jun Seo, Joon Seok, Mi-Kyung Lee\",\"doi\":\"10.4014/jmb.2502.02047\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Atopic dermatitis (AD) is a skin condition that can be exacerbated by particulate matter (PM). The primary causes of AD are believed to be impairments in the skin barrier, such as filaggrin (FLG) abnormalities. Although there is substantial evidence for genetic factors contributing to AD, it is challenging to attribute the disease's predisposition solely to genetics. We hypothesize that PM may induce epigenetic modifications in AD, impacting FLG expression. Here, we assessed histone deacetylases (HDACs) and FLG levels under AD conditions with or without exposure to PM using qRT-PCR, western blotting, and immunofluorescence. Additionally, we observed changes in these molecules when co-treated with the HDAC inhibitor, trichostatin A (TSA). FLG levels tended to decrease when PM or IL-4/13 were given individually, and a further decrease upon IL-4/13 and PM cotreatment. Interestingly, HDAC3 and HDAC6 are increased when they were both given PM10 and IL-4/13 co-treatment compared to IL-4/13 treatment alone. FLG levels exhibited a significant restoration and the levels of HDACs were changed when treated with TSA than with IL-4/13 or IL-4/13+PM co-treatment. We found changes in FLG and HDACs in the AD-like in vivo model and in this model with PM. Our findings suggest that PM can induce epigenetic alterations in AD. Treatment with TSA ameliorates these effects on FLG expression, indicating its potential as a novel therapeutic approach for AD.</p>\",\"PeriodicalId\":16481,\"journal\":{\"name\":\"Journal of microbiology and biotechnology\",\"volume\":\"35 \",\"pages\":\"e2502047\"},\"PeriodicalIF\":3.1000,\"publicationDate\":\"2025-07-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12324990/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of microbiology and biotechnology\",\"FirstCategoryId\":\"5\",\"ListUrlMain\":\"https://doi.org/10.4014/jmb.2502.02047\",\"RegionNum\":4,\"RegionCategory\":\"生物学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"BIOTECHNOLOGY & APPLIED MICROBIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of microbiology and biotechnology","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.4014/jmb.2502.02047","RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
特应性皮炎(AD)是一种可由颗粒物(PM)加重的皮肤病。阿尔茨海默病的主要原因被认为是皮肤屏障受损,如聚丝蛋白(FLG)异常。尽管有大量证据表明遗传因素会导致阿尔茨海默病,但将该疾病的易感性完全归因于遗传是具有挑战性的。我们假设PM可能诱导AD的表观遗传修饰,影响FLG的表达。在这里,我们使用qRT-PCR、western blotting和免疫荧光技术评估了暴露于PM或不暴露于PM的AD条件下组蛋白去乙酰化酶(hdac)和FLG水平。此外,当与HDAC抑制剂trichostatin A (TSA)共处理时,我们观察到这些分子的变化。单用PM或IL-4/13时,FLG水平呈下降趋势,IL-4/13与PM共用时,FLG水平进一步下降。有趣的是,与单独治疗IL-4/13相比,PM10和IL-4/13联合治疗时HDAC3和HDAC6增加。与IL-4/13或IL-4/13+PM联合治疗相比,TSA治疗组FLG水平明显恢复,hdac水平发生改变。我们在ad样体内模型和PM模型中发现FLG和hdac的变化。我们的研究结果表明,PM可以诱导AD的表观遗传改变。用TSA治疗可以改善FLG表达的这些影响,表明它有可能成为一种治疗AD的新方法。
Effect of Particulate Matter in Atopic Dermatitis through HDACs and Filaggrin Alteration.
Atopic dermatitis (AD) is a skin condition that can be exacerbated by particulate matter (PM). The primary causes of AD are believed to be impairments in the skin barrier, such as filaggrin (FLG) abnormalities. Although there is substantial evidence for genetic factors contributing to AD, it is challenging to attribute the disease's predisposition solely to genetics. We hypothesize that PM may induce epigenetic modifications in AD, impacting FLG expression. Here, we assessed histone deacetylases (HDACs) and FLG levels under AD conditions with or without exposure to PM using qRT-PCR, western blotting, and immunofluorescence. Additionally, we observed changes in these molecules when co-treated with the HDAC inhibitor, trichostatin A (TSA). FLG levels tended to decrease when PM or IL-4/13 were given individually, and a further decrease upon IL-4/13 and PM cotreatment. Interestingly, HDAC3 and HDAC6 are increased when they were both given PM10 and IL-4/13 co-treatment compared to IL-4/13 treatment alone. FLG levels exhibited a significant restoration and the levels of HDACs were changed when treated with TSA than with IL-4/13 or IL-4/13+PM co-treatment. We found changes in FLG and HDACs in the AD-like in vivo model and in this model with PM. Our findings suggest that PM can induce epigenetic alterations in AD. Treatment with TSA ameliorates these effects on FLG expression, indicating its potential as a novel therapeutic approach for AD.
期刊介绍:
The Journal of Microbiology and Biotechnology (JMB) is a monthly international journal devoted to the advancement and dissemination of scientific knowledge pertaining to microbiology, biotechnology, and related academic disciplines. It covers various scientific and technological aspects of Molecular and Cellular Microbiology, Environmental Microbiology and Biotechnology, Food Biotechnology, and Biotechnology and Bioengineering (subcategories are listed below). Launched in March 1991, the JMB is published by the Korean Society for Microbiology and Biotechnology (KMB) and distributed worldwide.